WO2024062349 - HYDROALCOHOLIC TOPICAL DICLOFENAC FORMULATIONS
National phase entry:
Publication Number
WO/2024/062349
Publication Date
28.03.2024
International Application No.
PCT/IB2023/059146
International Filing Date
14.09.2023
Title **
[English]
HYDROALCOHOLIC TOPICAL DICLOFENAC FORMULATIONS
[French]
FORMULATIONS TOPIQUES HYDROALCOOLIQUES DE DICLOFÉNAC
Applicants **
HALEON CH SARL
Inventors
BAKSHI, Pooja
BOZORG, Behnam Dasht
PATIL, Shantesh
Priority Data
22196980.1
21.09.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2066 | |
| EPO | Filing, Examination, Granting | 8372 | |
| Japan | Filing, Examination, Granting | 2198 | |
| South Korea | Filing, Examination, Granting | 2035 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,411
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Hydroalcoholic single phase gel compositions comprising diclofenac or a pharmaceutically acceptable salt of diclofenac are disclosed. The compositions are single phase compositions, and don't contain a lipophilic phase. The compositions are useful in the topical delivery of diclofenac. The compositions can be used in the treatment of for example pain, inflammation and swelling in soft-tissue injuries.[French]
L'invention concerne des compositions de gel monophasique hydroalcoolique comprenant du diclofénac ou un sel pharmaceutiquement acceptable de diclofénac. Les compositions sont des compositions monophasées, et ne contiennent pas de phase lipophile. Les compositions sont utiles dans l'administration topique de diclofénac. Les compositions peuvent être utilisées dans le traitement, par exemple, de la douleur, de l'inflammation et du gonflement dans des lésions des tissus mous.